Patents Assigned to Wellstat Therapeutics Coporation
  • Compositions and methods for treatment of mitochondrial diseases
    Patent number: 6956028
    Abstract: Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies.
    Type: Grant
    Filed: April 20, 2001
    Date of Patent: October 18, 2005
    Assignee: Wellstat Therapeutics Coporation
    Inventor: Reid W. von Borstel